Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC guideline vs. GOLD.
Chronic obstructive pulmonary disease
Enfermedad pulmonar obstructiva crónica
Guidelines
Normativa
Tratamiento
Treatment
Journal
Revista clinica espanola
ISSN: 2254-8874
Titre abrégé: Rev Clin Esp (Barc)
Pays: Spain
ID NLM: 101632437
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
14
12
2020
accepted:
27
01
2021
pubmed:
15
9
2021
medline:
15
12
2021
entrez:
14
9
2021
Statut:
ppublish
Résumé
Pharmacological treatment of chronic obstructive pulmonary disease in Spain is usually chosen according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) or Spanish guidelines for chronic obstructive pulmonary disease (GesEPOC). The main objective of this study was to evaluate the degree of concordance between treatment for newly diagnosed chronic obstructive pulmonary disease patients according to GOLD and GesEPOC. Simulation study. The following variables were used: FEV The database included 467 patients. Agreement between treatment decided using GOLD and GesEPOC was poor (Kappa: 0.17, 95% CI: 0.12-0.23). There is a poor agreement between GOLD and GesEPOC recommendations for initial chronic obstructive pulmonary disease treatment.
Identifiants
pubmed: 34518150
pii: S2254-8874(21)00128-4
doi: 10.1016/j.rceng.2021.01.009
pii:
doi:
Substances chimiques
Bronchodilator Agents
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
536-539Informations de copyright
Copyright © 2021 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.